Astera Labs holder plans $44.5M stock sale
Astera Labs, Inc. (ALAB) received a notice that Alba 2003 Living Trust intends to sell up to 150,000 shares of its common stock under Rule 144 through Morgan Stanley Smith Barney LLC Executive Financial Services.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Astera Labs, Inc. (ALAB) received a notice that Alba 2003 Living Trust intends to sell up to 150,000 shares of its common stock under Rule 144 through Morgan Stanley Smith Barney LLC Executive Financial Services. The notice lists an aggregate market value of $44,547,000.00 for these shares, compared with 173,485,104 shares of common stock outstanding.
The shares to be sold were acquired on 03/21/2018 via a private acquisition from the issuer for cash. The filing also reports recent 10b5-1 sales during the past three months by related entities, including sales of 170,000, 33,000, and 150,000 ALAB common shares.
Key Figures
Key Terms
Rule 144 regulatory
10b5-1 regulatory
Private Acquisition from Issuer or an Affiliate financial
Executive Financial Services financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Astera Labs, Inc. (ALAB) disclose in this Form 144?
What recent 10b5-1 sales of Astera Labs (ALAB) stock are reported in this Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.